{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:14Z","timestamp":1787020874391,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyper-IgE Syndrome, also known as Job\u2019s syndrome, is a rare primary immunodeficiency disorder characterized by recurrent infections and elevated levels of immunoglobulin E. While respiratory and systemic manifestations have been more emphasized, dermatological manifestations in Hyper-IgE Syndrome also play a significant role in disease presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This narrative review explores the dermatologic presentations of Hyper-IgE Syndrome in pediatric populations, including descriptions, associated symptoms\/findings, and available treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusion<\/jats:title>\n                    <jats:p>Neonatal rash, mucocutaneous candidiasis, noma neonatorum, psoriasis, cold staphylococcal abscesses, and candida onychomycosis are among the dermatological manifestations of Hyper-IgE Syndrome. Each manifestation has unique characteristics and treatment considerations, necessitating accurate recognition and diagnosis for effective management. Optimal treatment strategies involve a combination of supportive care, topical\/systemic therapies, antifungal medications, and surgical interventions when necessary. Further research is needed to enhance our understanding of these manifestations and evaluate treatment modalities for individuals affected by Hyper-IgE Syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-025-00963-6","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:39:27Z","timestamp":1746185967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dermatologic presentations of hyper IgE syndrome in pediatric patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Mohammad","family":"Mahjoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noosha","family":"Samieefar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Abdollahimajd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"3","key":"963_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","volume":"6","author":"Y Gernez","year":"2018","unstructured":"Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, et al. Autosomal dominant Hyper-IgE syndrome in the USIDNET registry. J Allergy Clin Immunol Pr. 20170919th ed. 2018;6(3):996\u20131001.","journal-title":"J Allergy Clin Immunol Pr"},{"key":"963_CR2","doi-asserted-by":"crossref","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Kashef S, Esmaeilzadeh E et al. Phenotyping and long-term follow up of patients with hyper IgE syndrome. Allergol Immunopathol (Madr). 20180929th ed. 2019;47(2):152\u20138.","DOI":"10.1016\/j.aller.2018.07.009"},{"key":"963_CR3","unstructured":"Hsu AP, Davis J, Puck JM, Holland SM, Freeman AF. STAT3 hyper IgE syndrome. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al. editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, SeattleCopyright \u00a9 1993\u20132023, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"1","key":"963_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1601-0825.2007.01363.x","volume":"14","author":"DL Domingo","year":"2008","unstructured":"Domingo DL, Freeman AF, Davis J, Puck JM, Tianxia W, Holland SM, et al. Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis. 2008;14(1):73\u201381.","journal-title":"Oral Dis"},{"issue":"2","key":"963_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0022-3476(98)70243-4","volume":"133","author":"WG Borges","year":"1998","unstructured":"Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR. The face of job. J Pediatr. 1998;133(2):303\u20135.","journal-title":"J Pediatr"},{"issue":"9","key":"963_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections\u2013an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692\u2013702.","journal-title":"N Engl J Med"},{"key":"963_CR7","unstructured":"Hafsi W, Yarrarapu SNS. Job Syndrome. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK525947\/"},{"issue":"9","key":"963_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archderm.140.9.1119","volume":"140","author":"CL Eberting","year":"2004","unstructured":"Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004;140(9):1119\u201325.","journal-title":"Arch Dermatol"},{"issue":"4","key":"963_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1067\/mpd.2002.127503","volume":"141","author":"SL Chamlin","year":"2002","unstructured":"Chamlin SL, McCalmont TH, Cunningham BB, Esterly NB, Lai CH, Mallory SB, et al. Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr. 2002;141(4):572\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"963_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jaad.2010.09.714","volume":"65","author":"A Olaiwan","year":"2011","unstructured":"Olaiwan A, Chandesris MO, Fraitag S, Lortholary O, Hermine O, Fischer A, et al. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol. 20110624th ed. 2011;65(6):1167\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"963_CR11","doi-asserted-by":"publisher","first-page":"1516068","DOI":"10.3389\/fimmu.2025.1516068","volume":"16","author":"R AlYafie","year":"2025","unstructured":"AlYafie R, Velayutham D, van Panhuys N, Jithesh PV. The genetics of hyper IgE syndromes. Front Immunol. 2025;16:1516068.","journal-title":"Front Immunol"},{"issue":"6","key":"963_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/ar4069","volume":"14","author":"PF Yong","year":"2012","unstructured":"Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An update on the hyper-IgE syndromes. Arthritis Res Ther. 20121130th ed. 2012;14(6):228.","journal-title":"Arthritis Res Ther"},{"key":"963_CR13","doi-asserted-by":"publisher","unstructured":"Szczawinska-Poplonyk A, Kycler Z, Pietrucha B, Heropolitanska-Pliszka E, Breborowicz A, Gerreth K. The hyperimmunoglobulin E syndrome - clinical manifestation diversity in primary immune deficiency. Orphanet J Rare Dis. 2011;6(1):76. Available from: https:\/\/doi.org\/10.1186\/1750-1172-6-76","DOI":"10.1186\/1750-1172-6-76"},{"issue":"7157","key":"963_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 20070805th ed. 2007;448(7157):1058\u201362.","journal-title":"Nature"},{"issue":"1","key":"963_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0091-6749(89)90471-5","volume":"83","author":"LJ Gorin","year":"1989","unstructured":"Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT. Burkitt\u2019s lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol. 1989;83(1):5\u201310.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"963_CR16","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/10428190400004463","volume":"45","author":"GD Leonard","year":"2004","unstructured":"Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, et al. Non-Hodgkin\u2019s lymphoma in job\u2019s syndrome: a case report and literature review. Leuk Lymphoma. 2004;45(12):2521\u20135.","journal-title":"Leuk Lymphoma"},{"key":"963_CR17","doi-asserted-by":"crossref","unstructured":"Asano T, Khourieh J, Zhang P, Rapaport F, Spaan AN, Li J et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 20210617th ed. 2021;218(8).","DOI":"10.1084\/jem.20202592"},{"issue":"6","key":"963_CR18","doi-asserted-by":"publisher","first-page":"e14003","DOI":"10.1097\/MD.0000000000014003","volume":"98","author":"Y Deng","year":"2019","unstructured":"Deng Y, Li T, Xie X, Xia D, Ding L, Xiang H, et al. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: two case reports. Med. 2019;98(6):e14003.","journal-title":"Med"},{"issue":"3","key":"963_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2018.194233","volume":"104","author":"T Shahin","year":"2019","unstructured":"Shahin T, Aschenbrenner D, Cagdas D, Bal SK, Conde CD, Garncarz W, et al. Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function. Haematologica. 20181011th ed. 2019;104(3):609\u201321.","journal-title":"Haematologica"},{"issue":"9","key":"963_CR20","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","volume":"214","author":"T Schwerd","year":"2017","unstructured":"Schwerd T, Twigg SRF, Aschenbrenner D, Manrique S, Miller KA, Taylor IB, et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med. 20170726th ed. 2017;214(9):2547\u201362.","journal-title":"J Exp Med"},{"key":"963_CR21","unstructured":"B\u00e9ziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24)."},{"key":"963_CR22","doi-asserted-by":"crossref","unstructured":"Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018;3(24).","DOI":"10.1126\/sciimmunol.aat4941"},{"key":"963_CR23","doi-asserted-by":"crossref","unstructured":"B\u00e9ziat V, Fieschi C, Momenilandi M, Migaud M, Belaid B, Djidjik R et al. Inherited human ZNF341 deficiency. Curr Opin Immunol. 2023 [cited 2023 Jun 25];82. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37080116\/","DOI":"10.1016\/j.coi.2023.102326"},{"issue":"1","key":"963_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","volume":"144","author":"ED Renner","year":"2004","unstructured":"Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144(1):93\u20139.","journal-title":"J Pediatr"},{"issue":"1","key":"963_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.iac.2018.08.007","volume":"39","author":"JRE Bergerson","year":"2019","unstructured":"Bergerson JRE, Freeman AF. An update on syndromes with a Hyper-IgE phenotype. Immunol Allergy Clin North Am. 2019;39(1):49\u201361.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3\u20134","key":"963_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1155\/2010\/607891","volume":"29","author":"HC Su","year":"2010","unstructured":"Su HC. Combined immunodeficiency associated with DOCK8 mutations and related immunodeficiencies. Dis Markers. 2010;29(3\u20134):121\u20132.","journal-title":"Dis Markers"},{"issue":"2","key":"963_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol. 20150128th ed. 2015;35(2):189\u201398.","journal-title":"J Clin Immunol"},{"key":"963_CR28","doi-asserted-by":"crossref","unstructured":"Yaakoubi R, Mekki N, Ben-Mustapha I, Ben-Khemis L, Bouaziz A, Ben Fraj I et al. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes. Front Immunol. 2023 [cited 2023 Jun 25];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36703986\/","DOI":"10.3389\/fimmu.2022.1057679"},{"issue":"7","key":"963_CR29","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 20220624th ed. 2022;42(7):1473\u2013507.","journal-title":"J Clin Immunol"},{"issue":"4","key":"963_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Med. 2012;91(4):e1\u201319.","journal-title":"Med"},{"key":"963_CR31","doi-asserted-by":"crossref","unstructured":"Saikia B, Rawat A, Minz RW, Suri D, Pandiarajan V, Jindal A et al. Clinical profile of Hyper-IgE syndrome in India. Front Immunol. 20210226th ed. 2021;12:626593.","DOI":"10.3389\/fimmu.2021.626593"},{"issue":"2","key":"963_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2332\/allergolint.12-RAI-0423","volume":"61","author":"Y Minegishi","year":"2012","unstructured":"Minegishi Y, Saito M. Cutaneous manifestations of hyper IgE syndrome. Allergol Int. 20120325th ed. 2012;61(2):191\u20136.","journal-title":"Allergol Int"},{"issue":"1","key":"963_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0190-9622(92)70156-A","volume":"27","author":"A Ta\u00efeb","year":"1992","unstructured":"Ta\u00efeb A, Bassan-Andrieu L, Maleville J. Eosinophilic pustulosis of the scalp in childhood. J Am Acad Dermatol. 1992;27(1):55\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"963_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1525-1470.1984.tb01116.x","volume":"1","author":"AW Lucky","year":"1984","unstructured":"Lucky AW, Esterly NB, Heskel N, Krafchik BR, Solomon LM. Eosinophilic pustular folliculitis in infancy. Pediatr Dermatol. 1984;1(3):202\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"963_CR35","first-page":"211","volume":"60","author":"S Ghosh","year":"2015","unstructured":"Ghosh S. Neonatal pustular dermatosis: an overview. Indian J Dermatol. 2015;60(2):211.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"963_CR36","first-page":"153","volume":"58","author":"RA Schwartz","year":"1996","unstructured":"Schwartz RA, Janniger CK. Erythema toxicum neonatorum. Cutis. 1996;58(2):153\u20135.","journal-title":"Cutis"},{"issue":"3","key":"963_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1034\/j.1399-3038.2000.00091.x","volume":"11","author":"MD Erlewyn-Lajeunesse","year":"2000","unstructured":"Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000;11(3):133\u201341.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"963_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000351912","volume":"6","author":"SP Smeekens","year":"2014","unstructured":"Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PL, Schalkwijk J, et al. Skin microbiome imbalance in patients with STAT1\/STAT3 defects impairs innate host defense responses. J Innate Immun. 2014;6(3):253\u201362. 20130622nd ed.","journal-title":"J Innate Immun"},{"issue":"6","key":"963_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/emmm.201201678","volume":"5","author":"SP Smeekens","year":"2013","unstructured":"Smeekens SP, van de Veerdonk FL, Kullberg BJ, Netea MG. Genetic susceptibility to Candida infections. EMBO Mol Med. 20130430th ed. 2013;5(6):805\u201313.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"963_CR40","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551\u20137.","journal-title":"J Exp Med"},{"issue":"7188","key":"963_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 20080312th ed. 2008;452(7188):773\u20136.","journal-title":"Nature"},{"issue":"7","key":"963_CR42","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","volume":"205","author":"L de Beaucoudrey","year":"2008","unstructured":"de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543\u201350.","journal-title":"J Exp Med"},{"issue":"3","key":"963_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1468-3083.2006.01918.x","volume":"21","author":"XL Li","year":"2007","unstructured":"Li XL, Geng SM, Lei XB, Xiao SX, Liu Y, Peng ZH. Unusual psoriasiform lesions in a patient with Hyper-IgE syndrome. J Eur Acad Dermatol Venereol. 2007;21(3):424\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"963_CR44","first-page":"735","volume":"4","author":"J Ghaffari","year":"2013","unstructured":"Ghaffari J, Abedian-Kenari S, Ghasemi M, Gohardehi F. Psoriasis in hyper IgE syndrome - a case report. Casp J Intern Med. 2013;4(3):735\u20138.","journal-title":"Casp J Intern Med"},{"issue":"1","key":"963_CR45","first-page":"34","volume":"9","author":"C BG","year":"2020","unstructured":"BG C, BC GM. Neonate presenting with multiple cold abscesses: A rare case of job \u2019 s syndrome. Med Innov. 2020;9(1):34\u20136.","journal-title":"Med Innov"},{"key":"963_CR46","doi-asserted-by":"crossref","unstructured":"Akira S, Nishio Y, Inoue M, Wang XJ, We S, Matsusaka T et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 1994;77(1):63\u201371. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/0092867494902356","DOI":"10.1016\/0092-8674(94)90235-6"},{"issue":"7","key":"963_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2340\/00015555-3182","volume":"99","author":"P Zou","year":"2019","unstructured":"Zou P, Tang R, Chen P, Qiu X, Zhang G, Zhan Y, et al. Hyper IgE syndrome with large recurrent head abscesses misdiagnosed as folliculitis. Acta Derm Venereol. 2019;99(7):697\u20138.","journal-title":"Acta Derm Venereol"},{"key":"963_CR48","doi-asserted-by":"crossref","unstructured":"Nucci F, Nou\u00e9r SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. Clin Microbiol Infect. 20180519th ed. 2018;24(10):1105.e1-1105.e4.","DOI":"10.1016\/j.cmi.2018.05.006"},{"issue":"4","key":"963_CR49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00014-07","volume":"20","author":"M Nucci","year":"2007","unstructured":"Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695\u2013704.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"963_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00014-07","volume":"20","author":"MS Lionakis","year":"2007","unstructured":"Lionakis MS, Kontoyiannis DP, Nucci M, Anaissie E, Nucci F, Nou\u00e9r SA, et al. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 20180519th ed. 2007;20(4):695\u2013704.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"963_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10875-022-01404-4","volume":"43","author":"S Abbara","year":"2022","unstructured":"Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, et al. Primary invasive cutaneous fusariosis in patients with STAT3 Hyper-IgE syndrome. J Clin Immunol. 20221212th ed. 2022;43(3):647\u201352.","journal-title":"J Clin Immunol"},{"issue":"1","key":"963_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12016-009-8134-1","volume":"38","author":"J Heimall","year":"2010","unstructured":"Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010;38(1):32\u20138.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"963_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"S Sano","year":"2008","unstructured":"Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50(1):1\u201314. 20070702nd ed.","journal-title":"J Dermatol Sci"},{"issue":"10247","key":"963_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345\u201360.","journal-title":"Lancet"},{"issue":"1","key":"963_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233\u201346.","journal-title":"Immunol Rev"},{"issue":"6","key":"963_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.coi.2011.09.007","volume":"23","author":"N Novak","year":"2011","unstructured":"Novak N, Leung DY. Advances in atopic dermatitis. Curr Opin Immunol. 20111019th ed. 2011;23(6):778\u201383.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"963_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1542\/peds.49.1.59","volume":"49","author":"RH Buckley","year":"1972","unstructured":"Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59\u201370.","journal-title":"Pediatrics"},{"issue":"4","key":"963_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng0406-399","volume":"38","author":"TJ Hudson","year":"2006","unstructured":"Hudson TJ. Skin barrier function and allergic risk. Nat Genet. 2006;38(4):399\u2013400.","journal-title":"Nat Genet"},{"issue":"4","key":"963_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein Filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 20060319th ed. 2006;38(4):441\u20136.","journal-title":"Nat Genet"},{"issue":"Suppl 3","key":"963_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jdv.12480","volume":"28","author":"A Torrelo","year":"2014","unstructured":"Torrelo A. Atopic dermatitis in different skin types. What is to know? J Eur Acad Dermatol Venereol. 2014;28(Suppl 3):2\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"963_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0889-8588(18)30632-4","volume":"2","author":"DY Leung","year":"1988","unstructured":"Leung DY, Geha RS. Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am. 1988;2(1):81\u2013100.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"963_CR62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/ped.2012.0179","volume":"26","author":"O Cavkaytar","year":"2013","unstructured":"Cavkaytar O, Cagdas Ayvaz D, Keskin O, Arik Yilmaz E, Buyuktiryaki B, Sahiner UM, et al. A case of DOCK8 deficient Hyper-IgE syndrome presenting primarily with eczema, food allergy, and asthma. Pediatr Allergy Immunol Pulmonol. 20121114th ed. 2013;26(1):48\u201351.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"7445","key":"963_CR63","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","volume":"1","author":"SD Davis","year":"1966","unstructured":"Davis SD, Schaller J, Wedgwood RJ. Job\u2019s syndrome. Recurrent, cold, Staphylococcal abscesses. Lancet. 1966;1(7445):1013\u20135.","journal-title":"Lancet"},{"issue":"6","key":"963_CR64","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10875-022-01293-7","volume":"42","author":"V Schwierzeck","year":"2022","unstructured":"Schwierzeck V, Effner R, Abel F, Reiger M, Notheis G, Held J, et al. Molecular assessment of Staphylococcus Aureus strains in STAT3 Hyper-IgE syndrome patients. J Clin Immunol. 2022;42(6):1301\u20139. 20220602nd ed.","journal-title":"J Clin Immunol"},{"key":"963_CR65","doi-asserted-by":"crossref","unstructured":"Park B, Liu GY. Staphylococcus aureus and Hyper-IgE syndrome. Int J Mol Sci 20201201st ed. 2020;21(23).","DOI":"10.3390\/ijms21239152"},{"key":"963_CR66","doi-asserted-by":"crossref","unstructured":"Markman M. Cancer medicine 6. Cancer. 2003;98(11):2521. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cncr.11824","DOI":"10.1002\/cncr.11824"},{"issue":"11","key":"963_CR67","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3(11):991\u20138.","journal-title":"Nat Immunol"},{"issue":"6","key":"963_CR68","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","volume":"26","author":"DE Rowe","year":"1992","unstructured":"Rowe DE, Carroll RJ, Day Jr. CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"963_CR69","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1097\/MPH.0000000000000954","volume":"40","author":"AS Sasihuseyinoglu","year":"2018","unstructured":"Sasihuseyinoglu AS, Yilmaz M, Altinta\u015f DU, Dogruel D, Serbes M, U\u011fuz AH, et al. Squamous cell carcinoma with Hyper-IgE syndrome: A case report. J Pediatr Hematol Oncol. 2018;40(6):e380\u20132.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"963_CR70","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0030-6665(20)31213-5","volume":"23","author":"GJ Hruza","year":"1990","unstructured":"Hruza GJ. Mohs micrographic surgery. Otolaryngol Clin North Am. 1990;23(5):845\u201364.","journal-title":"Otolaryngol Clin North Am"},{"issue":"4","key":"963_CR71","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jaip.2021.01.037","volume":"9","author":"PC Stadler","year":"2021","unstructured":"Stadler PC, Renner ED, Milner J, Wollenberg A. Inborn error of immunity or atopic dermatitis: when to be concerned and how to investigate. J Allergy Clin Immunol Pract. 2021;9(4):1501\u20137.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00963-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-025-00963-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00963-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:02:04Z","timestamp":1746190924000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-025-00963-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s13223-025-00963-6","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not applicable to review studies. Informed consent was obtained from the patient for the picture.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for the picture publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}